Imperial College London – DIAMONDS

12th February 2020

Here at greensplash, we are extremely proud of the long-term relationships that we build with our valued clients. We have worked in partnership with Imperial College London for a number of years now on various research projects, and we are pleased to announce our involvement in a new project – DIAMONDS.

Led by Imperial College London, this landmark project is a €22.5 million project funded by the European Commission involving 28 institutions across 13 countries. DIAMONDS is about developing a rapid test to diagnose severe illnesses, using personalised gene signatures. The team will show that the cause of a fever for example, can be achieved using the gene expression signatures in a patient’s blood sample. The DIAMONDS scientists have termed this Personalised Molecular Signature Diagnosis (PMSD). The scientists hope this test will streamline diagnosis of serious conditions such as pneumonia, tuberculosis, sepsis, meningitis, and inflammatory and immune diseases to under two hours thus avoiding unnecessary invasive investigations and treatments.

Over the coming weeks we will be working on designing and developing an engaging and informative website for this important research project that accurately conveys the work that will be undertaken over the course of the next five years to develop this test. With partners from around the world contributing to this, we will be providing copyediting services, along with SEO services to ensure the new website performs in search engines.

We are extremely proud to be working with Imperial College London once again and are honoured to be a part of this ground breaking new project that will have an incredible impact on patients, public health care systems and health care providers.

To utilise our expertise and experience in web design, copywriting, SEO and more, please feel free to give us a call on 01606 884123 or email us at hello@greensplash.com today!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196.